LifeStance Health (LFST) Invested Capital (2020 - 2026)

LifeStance Health (LFST) has 7 years of Invested Capital data on file, last reported at $1.5 billion in Q1 2026.

• Invested Capital for Q1 2026 came in at $1.5 billion, up 1.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 1.39% YoY), and the FY2025 annual result was $1.5 billion, up 5.17% from the prior year.
• Invested Capital retreated to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Over five years, Invested Capital peaked at $1.6 billion in Q1 2022 and troughed at $1.4 billion in Q1 2024.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2026 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital jumped 63.1% in 2022, then dropped 6.35% in 2023.
• A 5-year view of Invested Capital shows it stood at $1.5 billion in 2022, then fell by 6.35% to $1.4 billion in 2023, then climbed by 0.64% to $1.4 billion in 2024, then rose by 5.17% to $1.5 billion in 2025, then declined by 2.87% to $1.5 billion in 2026.
• Business Quant data shows LFST's Invested Capital at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.